Erschienen in:
01.03.2007 | Editorial
Academic medical centers, private industry, and clinical trials: how do we achieve fairness, objectivity, and balance?
verfasst von:
Raymond T. Foster Sr
Erschienen in:
International Urogynecology Journal
|
Ausgabe 3/2007
Einloggen, um Zugang zu erhalten
Excerpt
The availability of funding for biomedical research from public sources is diminishing in industrialized nations. Many of these countries have historically committed enormous resources to the medical research process. In the US, the budget of the National Institutes of Health (NIH), which provides the majority of public research funding for clinical and basic science investigations, has remained nearly unaltered for four consecutive years. In fact, the NIH budget has consistently been $28 billion (USD) for the last 2 years and is already projected to remain at this level for the next fiscal year, despite the rising cost of research related to inflation in our economy [
1]. As investigators, we must seek other funding opportunities to continue the acquisition of new knowledge at a pace demanded by our patients. …